MRPL21
gene geneOn this page
Also known as bL21m
Summary
MRPL21 (mitochondrial ribosomal protein L21, HGNC:14479) is a protein-coding gene on chromosome 11q13.3, encoding Large ribosomal subunit protein bL21m (Q7Z2W9). It is a selective cancer dependency (DepMap: 83.7% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Multiple transcript variants encoding different isoforms were identified through sequence analysis although some may be subject to nonsense-mediated decay (NMD).
Source: NCBI Gene 219927 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 43 total
- GTEx eGene: eQTL in 50 tissues, sQTL in 48 (q < 0.05)
- Cancer dependency (DepMap): dependent in 83.7% of screened cell lines
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 0.96 (unconstrained)
- MANE Select transcript:
NM_181514 - Interaction hub: 2,459 STRING partners (top 4% of genes corpus-wide)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14479 |
| Approved symbol | MRPL21 |
| Name | mitochondrial ribosomal protein L21 |
| Location | 11q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bL21m |
| Ensembl gene | ENSG00000197345 |
| Ensembl biotype | protein_coding |
| OMIM | 611834 |
| Entrez | 219927 |
Gene structure
Transcript identifiers
Ensembl transcripts: 40 — 28 nonsense_mediated_decay, 11 protein_coding, 1 retained_intron
MANE Select: ENST00000362034
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 3, TSL 3: 1, TSL 4: 1, TSL 5: 2
ENST00000362034, ENST00000450904, ENST00000536637, ENST00000541265, ENST00000541279, ENST00000544567, ENST00000565125, ENST00000567045, ENST00000918367, ENST00000918368, ENST00000976719, ENST00000976720, ENST00000976721, ENST00000976722, ENST00000976723, ENST00001037128, ENST00001037129, ENST00001037130, ENST00001062026, ENST00001062027, ENST00001062028, ENST00001062032, ENST00001062034, ENST00001062035, ENST00001062036, ENST00001062038, ENST00001062040, ENST00001062041, ENST00001062048, ENST00001062049, ENST00001062050, ENST00001062051, ENST00001062054, ENST00001062055, ENST00001094720, ENST00001094721, ENST00001094722, ENST00001094723, ENST00001131099, ENST00001142661
RefSeq mRNA: 2 — MANE Select: NM_181514
NM_181514, NM_181515
CCDS: CCDS44662, CCDS8186
Canonical transcript exons
ENST00000362034 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002290904 | 68903723 | 68903832 |
| ENSE00003467884 | 68893403 | 68893455 |
| ENSE00003563014 | 68892890 | 68892993 |
| ENSE00003623114 | 68896515 | 68896678 |
| ENSE00003625649 | 68900548 | 68900605 |
| ENSE00003653786 | 68897927 | 68898012 |
| ENSE00003841996 | 68891278 | 68891395 |
Expression profiles
Bgee: expression breadth ubiquitous, 248 present calls, max score 97.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.9932 / max 480.7127, expressed in 1790 samples.
Highest expression (Bgee): ventricle myocardium, mucosa of transverse colon, apex of heart, heart left ventricle, cardiac ventricle.
Genetic regulation across tissues (GTEx eQTL / sQTL)
MRPL21 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 50 tissues and its splicing (sQTL) in 48 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 98 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Artery Tibial | eqtl | 3.8e-204 | -0.79 | 11:68885764:C:T |
| Skin Sun Exposed Lower leg | eqtl | 1.4e-194 | -0.84 | 11:68903812:G:GCCGCCGCCATCTTC |
| Thyroid | eqtl | 1.9e-181 | -0.86 | 11:68903812:G:GCCGCCGCCATCTTC |
| Cells Cultured fibroblasts | eqtl | 7.4e-179 | -0.56 | 11:68885764:C:T |
| Nerve Tibial | eqtl | 2.2e-164 | -0.85 | 11:68903812:G:GCCGCCGCCATCTTC |
| Esophagus Mucosa | eqtl | 1.3e-161 | -0.80 | 11:68885764:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 4.4e-160 | -0.85 | 11:68885764:C:T |
| Esophagus Muscularis | eqtl | 8.7e-159 | -0.86 | 11:68885764:C:T |
| Adipose Subcutaneous | eqtl | 1.9e-153 | -0.76 | 11:68885764:C:T |
| Artery Aorta | eqtl | 8.4e-135 | -0.88 | 11:68903812:G:GCCGCCGCCATCTTC |
| Colon Transverse | eqtl | 9.1e-130 | -0.83 | 11:68885764:C:T |
| Colon Sigmoid | eqtl | 1.3e-118 | -0.95 | 11:68885764:C:T |
| Whole Blood | eqtl | 8.1e-117 | -0.51 | 11:68885764:C:T |
| Lung | eqtl | 1.0e-113 | -0.57 | 11:68885764:C:T |
| Esophagus Gastroesophageal Junction | eqtl | 5.3e-112 | -0.94 | 11:68885764:C:T |
| Adipose Visceral Omentum | eqtl | 5.2e-110 | -0.67 | 11:68885764:C:T |
| Testis | eqtl | 1.5e-104 | -0.97 | 11:68885764:C:T |
| Cells EBV-transformed lymphocytes | eqtl | 4.8e-103 | -0.77 | 11:68885764:C:T |
| Breast Mammary Tissue | eqtl | 3.5e-98 | -0.68 | 11:68885764:C:T |
| Pituitary | eqtl | 5.9e-95 | -1.11 | 11:68885764:C:T |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121021 | 33.5305 | 1787 |
| 121020 | 0.4627 | 241 |
Top tissues by expression
showing 100 of 255 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 97.51 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.94 | gold quality |
| apex of heart | UBERON:0002098 | 96.88 | gold quality |
| heart left ventricle | UBERON:0002084 | 96.85 | gold quality |
| cardiac ventricle | UBERON:0002082 | 96.67 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.64 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.47 | gold quality |
| muscle of leg | UBERON:0001383 | 96.46 | gold quality |
| cardiac atrium | UBERON:0002081 | 96.37 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.30 | gold quality |
| heart | UBERON:0000948 | 96.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.07 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.04 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 95.89 | gold quality |
| transverse colon | UBERON:0001157 | 95.80 | gold quality |
| kidney epithelium | UBERON:0004819 | 95.65 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.62 | gold quality |
| tibialis anterior | UBERON:0001385 | 95.58 | gold quality |
| myocardium | UBERON:0002349 | 95.50 | gold quality |
| hypothalamus | UBERON:0001898 | 95.43 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 95.41 | gold quality |
| popliteal artery | UBERON:0002250 | 95.34 | gold quality |
| tibial artery | UBERON:0007610 | 95.34 | gold quality |
| lower esophagus | UBERON:0013473 | 95.34 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.34 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.33 | gold quality |
| right coronary artery | UBERON:0001625 | 95.20 | gold quality |
| right frontal lobe | UBERON:0002810 | 95.20 | gold quality |
| minor salivary gland | UBERON:0001830 | 95.11 | gold quality |
| aorta | UBERON:0000947 | 95.00 | gold quality |
| amygdala | UBERON:0001876 | 94.96 | gold quality |
| body of uterus | UBERON:0009853 | 94.92 | gold quality |
| left uterine tube | UBERON:0001303 | 94.90 | gold quality |
| left coronary artery | UBERON:0001626 | 94.85 | gold quality |
| right uterine tube | UBERON:0001302 | 94.79 | gold quality |
| body of stomach | UBERON:0001161 | 94.78 | gold quality |
| thoracic aorta | UBERON:0001515 | 94.72 | gold quality |
| ascending aorta | UBERON:0001496 | 94.71 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 94.69 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.68 | gold quality |
| endocervix | UBERON:0000458 | 94.61 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.61 | gold quality |
| putamen | UBERON:0001874 | 94.57 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.54 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.54 | gold quality |
| esophagus | UBERON:0001043 | 94.50 | gold quality |
| left ovary | UBERON:0002119 | 94.48 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.47 | gold quality |
| colon | UBERON:0001155 | 94.44 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.44 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.43 | gold quality |
| body of pancreas | UBERON:0001150 | 94.42 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.42 | gold quality |
| skin of leg | UBERON:0001511 | 94.41 | gold quality |
| right ovary | UBERON:0002118 | 94.41 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 94.40 | gold quality |
| coronary artery | UBERON:0001621 | 94.38 | gold quality |
| ectocervix | UBERON:0012249 | 94.37 | gold quality |
| large intestine | UBERON:0000059 | 94.34 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.34 | gold quality |
| rectum | UBERON:0001052 | 94.28 | gold quality |
| ileal mucosa | UBERON:0000331 | 94.14 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.09 | gold quality |
| muscle tissue | UBERON:0002385 | 94.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.05 | gold quality |
| right testis | UBERON:0004534 | 94.05 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.04 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.02 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.96 | gold quality |
| intestine | UBERON:0000160 | 93.95 | gold quality |
| left testis | UBERON:0004533 | 93.92 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.90 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 93.87 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 93.87 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.84 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.84 | gold quality |
| cerebellum | UBERON:0002037 | 93.83 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.76 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 93.75 | gold quality |
| cortex of kidney | UBERON:0001225 | 93.70 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.70 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.68 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.61 | gold quality |
| pancreas | UBERON:0001264 | 93.58 | gold quality |
| upper arm skin | UBERON:0004263 | 93.58 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.55 | gold quality |
| frontal cortex | UBERON:0001870 | 93.54 | gold quality |
| substantia nigra | UBERON:0002038 | 93.53 | gold quality |
| tibial nerve | UBERON:0001323 | 93.48 | gold quality |
| thyroid gland | UBERON:0002046 | 93.47 | gold quality |
| neocortex | UBERON:0001950 | 93.44 | gold quality |
| mouth mucosa | UBERON:0003729 | 93.44 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.43 | gold quality |
| omental fat pad | UBERON:0010414 | 93.34 | gold quality |
| peritoneum | UBERON:0002358 | 93.31 | gold quality |
| mucosa of stomach | UBERON:0001199 | 93.25 | gold quality |
| stomach | UBERON:0000945 | 93.23 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.17 | gold quality |
| monocyte | CL:0000576 | 93.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.23 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 79 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Skeletal muscle | tissue | 122.8 | not detected |
| Tongue | tissue | 101.6 | |
| Salivary gland | tissue | 93.6 | medium |
| Heart muscle | tissue | 93.0 | low |
| Bone marrow | tissue | 57.0 | low |
| Frontal cortex | tissue | 54.1 | |
| Parathyroid gland | tissue | 52.8 | medium |
| Liver | tissue | 50.9 | not detected |
| Caudate putamen | tissue | 50.1 | |
| Ovary | tissue | 49.2 | not detected |
| Breast | tissue | 49.1 | medium |
| Kidney | tissue | 49.0 | medium |
| Colon | tissue | 46.6 | medium |
| Epididymis | tissue | 45.6 | medium |
| Esophagus | tissue | 45.5 | medium |
| Pancreas | tissue | 45.3 | medium |
| Vagina | tissue | 43.1 | medium |
| Pituitary gland | tissue | 42.7 | |
| Fallopian tube | tissue | 42.5 | medium |
| Thyroid gland | tissue | 41.9 | medium |
| Lymph node | tissue | 41.0 | medium |
| Urinary bladder | tissue | 40.7 | medium |
| Tonsil | tissue | 40.2 | medium |
| Rectum | tissue | 39.8 | medium |
| Small intestine | tissue | 38.8 | medium |
| Seminal vesicle | tissue | 36.8 | medium |
| Locus coeruleus | tissue | 36.8 | |
| Duodenum | tissue | 36.3 | medium |
| Choroid plexus | tissue | 35.7 | |
| Cervix | tissue | 35.4 | medium |
| Postcentral gyrus | tissue | 34.9 | |
| Thymus | tissue | 34.6 | |
| Skin 1 | tissue | 34.2 | medium |
| Adrenal gland | tissue | 33.3 | medium |
| Prostate | tissue | 33.0 | low |
| Smooth muscle | tissue | 32.7 | medium |
| Appendix | tissue | 32.0 | medium |
| Stomach 1 | tissue | 31.3 | medium |
| Placenta | tissue | 31.0 | medium |
| Nucleus accumbens | tissue | 30.4 | |
| Adipose tissue | tissue | 29.0 | not detected |
| Hippocampus | tissue | 28.8 | not detected |
| Endometrium 1 | tissue | 28.7 | not detected |
| Retina | tissue | 27.5 | |
| Testis | tissue | 25.6 | medium |
| Gallbladder | tissue | 25.4 | medium |
| Lung | tissue | 24.0 | not detected |
| Spleen | tissue | 22.8 | medium |
| Thalamus | tissue | 12.7 | |
| Superior colliculi | tissue | 11.8 | |
| Pons | tissue | 11.6 | |
| Cerebral cortex | tissue | 11.5 | low |
| Somatosensory cortex | tissue | 11.5 | |
| Hippocampal formation | tissue | 11.2 | |
| Midbrain | tissue | 11.0 | |
| Motor cortex | tissue | 10.5 | |
| Medulla oblongata | tissue | 10.5 | |
| Occipital cortex | tissue | 10.4 | |
| Putamen | tissue | 10.3 | |
| Substantia nigra | tissue | 10.2 |
Brain sub-regions (HPA Brain Atlas): detected in 191; highest nTPM — Blood vessel (60.3), Cerebellar nuclei (46.3), Lateral hypothalamic area (39.5), Spinal trigeminal nucleus, interpolar (39.5), Pontine raphe nucleus (39.3).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TEAD1
Functional genomics
gnomAD constraint: pLI 6.69e-05, LOEUF 0.964, missense Z 0.277 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000362034 — one region, missense o/e 0.99.
DepMap (CRISPR cell-line fitness): dependent in 83.7% of screened cell lines.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): SF-295 (-2.04), COR-L311 (-1.939), T.T (-1.844), OCI-AML2 (-1.806), SNU-398 (-1.801), SLR 20 (-1.789), U-937 (-1.763), NCI-H1437 (-1.752), SU-DHL-10 (-1.721), SNU-869 (-1.701), LN-428 (-1.671), ACC-MESO-1 (-1.638), JHH-4 (-1.632), NCI-H1581 (-1.616), SU-DHL-4 (-1.587).
Literature-anchored findings (GeneRIF, showing 2)
- High MRPL21 expression is associated with esophageal squamous cell carcinoma. (PMID:26406417)
- MRPL21 promotes HCC proliferation through TP53 mutation-induced apoptotic resistance. (PMID:38181584)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl21 | ENSDARG00000003846 |
| mus_musculus | Mrpl21 | ENSMUSG00000024829 |
| rattus_norvegicus | Mrpl21 | ENSRNOG00000013845 |
| drosophila_melanogaster | mRpL21 | FBGN0036853 |
| caenorhabditis_elegans | WBGENE00023422 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q2TBS2 | 81.4% | Diamond |
| Neurospora crassa OR74A | Q7SGE5 | 39.3% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CPT1A | protein-coding | 1374 |
| IGHMBP2 | protein-coding | 3508 |
| MRGPRF-AS1 | ncRNA | 101928200 |
| MRGPRF | protein-coding | 116535 |
| LINC02701 | ncRNA | 105369364 |
| TESMIN | protein-coding | 9633 |
| MRGPRD | protein-coding | 116512 |
Protein
Protein identifiers
Large ribosomal subunit protein bL21m — Q7Z2W9 (reviewed: Q7Z2W9)
Alternative names: 39S ribosomal protein L21, mitochondrial
All UniProt accessions (5): Q7Z2W9, F5H3L0, F5H4R5, F5H7V8, H3BUY0
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the bacterial ribosomal protein bL21 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z2W9-1 | 1 | yes |
| Q7Z2W9-2 | 2 |
RefSeq proteins (2): NP_852615, NP_852616 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001787 | Ribosomal_bL21 | Family |
| IPR028909 | bL21-like | Family |
| IPR036164 | bL21-like_sf | Homologous_superfamily |
Pfam: PF00829
UniProt features (22 total): strand 10, helix 6, turn 3, transit peptide 1, chain 1, splice variant 1
Structure
Experimental structures (PDB)
showing 30 of 92 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 7OF0 | Structure of a human mitochondrial ribosome large subunit assembly intermediate in … | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | Human mitochondrial ribosome at 2.2 A resolution (bound to partly built tRNAs and mRNA) | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | Human mitochondrial ribosome in complex with antibiotic tigecycline | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | mt-LSU assembly intermediate in GTPBP8 knock-out cells, state 2 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | Membrane-associated human mitoribosome in complex with TACO1 | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | Structure of a human mitochondrial ribosome large subunit assembly intermediate in … | ELECTRON MICROSCOPY | 2.5 |
| 7PO4 | Assembly intermediate of human mitochondrial ribosome large subunit (largely unfolded … | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | Human mitochondrial ribosome in complex with mRNA, A/A tRNA and P/P tRNA | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | Human mitochondrial ribosome large subunit assembly intermediate with MTERF4-NSUN4, MRM2 … | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | Structure of mature human mitochondrial ribosome large subunit in complex with GTPBP6 … | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | Human 39S mitoribosome in complex with antibiotic Linezolid | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | Human mitochondrial ribosome in complex with mRNA, A/A-, P/P- and E/E-tRNAs at 2.63 A … | ELECTRON MICROSCOPY | 2.63 |
| 9RU6 | Human mitoribosome bound to TACO1 (Translational activator of COX1), mRNA, A/A-, P/P- and … | ELECTRON MICROSCOPY | 2.64 |
| 7OF2 | Structure of a human mitochondrial ribosome large subunit assembly intermediate in … | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | Structure of a human mitochondrial ribosome large subunit assembly intermediate in … | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | Structure of mature human mitochondrial ribosome large subunit in complex with GTPBP6 … | ELECTRON MICROSCOPY | 2.7 |
| 8QU1 | mt-LSU assembly intermediate in GTPBP8 knock-out cells, state 1 | ELECTRON MICROSCOPY | 2.74 |
| 9PR4 | In Situ Structure of the Human Mitochondrial Large Subunit 39S in Complex with TACO1 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | In Situ Structure of the Human Mitoribosome Large Subunit 39S in Complex with EF-Tu | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | Human mitochondrial ribosome in complex with LRPPRC, SLIRP, A-site, P-site, E-site tRNAs … | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | Human mitochondrial ribosome in complex with OXA1L, mRNA, A/A tRNA, P/P tRNA and nascent … | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | Cryo-EM structure of the human mtLSU assembly intermediate upon MRM2 depletion - class 4 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | State A of the human mitoribosomal large subunit assembly intermediate | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | Structure of a human mitochondrial ribosome large subunit assembly intermediate in … | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | Cryo-EM structure of the human 55S mitoribosome with Tigecycline | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | 39S human mitochondrial large ribosomal subunit with mtRF1 and P-site tRNA | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | In situ structure of the human mitoribosome in the A-P state with TACO1 | ELECTRON MICROSCOPY | 2.9 |
| 9VXM | Human mitoribosome in a non-rotated state, with multiple neomycin molecules bound … | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | In situ structure of the human mitoribosome in the P state | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | Structure of the human mitochondrial ribosome-EF-G1 complex (ClassIII) | ELECTRON MICROSCOPY | 2.96 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z2W9-F1 | 85.74 | 0.74 |
Human Protein Atlas
Protein class: Ribosomal proteins, Predicted intracellular proteins, Essential proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mitochondria; nucleoplasm
Antibody reliability (HPA): IH approved · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 7; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
7 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control | curated |
| R-HSA-5419276 | Mitochondrial translation termination | curated |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-5368287 | Mitochondrial translation | — |
| R-HSA-5389840 | Mitochondrial translation elongation | electronic |
| R-HSA-5368286 | Mitochondrial translation initiation | electronic |
| R-HSA-72766 | Translation | — |
MSigDB gene sets: 106 (showing top):
MODULE_151, GOBP_MITOCHONDRIAL_TRANSLATION, chr11q13, GOBP_TRANSLATION, GGAANCGGAANY_UNKNOWN, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, AAAGACA_MIR511, GOCC_MITOCHONDRIAL_ENVELOPE, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, MODULE_114, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (2): mitochondrial translation (GO:0032543), translation (GO:0006412)
GO Molecular Function (2): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial large ribosomal subunit (GO:0005762), cytoplasm (GO:0005737), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
3 top-level categories:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
24 GO namespaces:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 10 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| mitochondrial large ribosomal subunit | CC | direct assay |
| mitochondrion | CC | direct assay |
| RNA binding | MF | high-throughput assay |
Protein interactions and networks
STRING
showing 15 of 2,459 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL21 | MRPL11 | Q9Y3B7 | 689 |
| MRPL21 | MRPL16 | Q9NX20 | 667 |
| MRPL21 | MRPL17 | Q9NRX2 | 549 |
| MRPL21 | MRPL36 | Q9P0J6 | 549 |
| MRPL21 | MRPS11 | P82912 | 542 |
| MRPL21 | MRPL33 | O75394 | 528 |
| MRPL21 | MRPL24 | Q96A35 | 526 |
| MRPL21 | MRPL9 | Q9BYD2 | 522 |
| MRPL21 | MRPL13 | Q9BYD1 | 520 |
| MRPL21 | MRPS10 | P82664 | 506 |
| MRPL21 | MRPL3 | P09001 | 497 |
| MRPL21 | MRPS14 | O60783 | 492 |
| MRPL21 | MRPL12 | P52815 | 490 |
| MRPL21 | MRPS16 | Q9Y3D3 | 477 |
| MRPL21 | MRPL1 | Q9BYD6 | 454 |
IntAct
Human interaction partners of MRPL21 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
4 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| TSC2 | physical association | 0.370 | 1 |
| FDXR | association | 0.350 | 1 |
| GTPBP6 | association | 0.350 | 1 |
| RPL3 | association | 0.350 | 1 |
BioGRID (234 interactions; top human partners by supporting records): MRPL4 (Affinity Capture-MS; 4 records), MRPL50 (Affinity Capture-MS; 4 records), MRPS30 (Affinity Capture-MS; 4 records), AUH (Affinity Capture-MS; 3 records), GRSF1 (Proximity Label-MS; 3 records), MRPL30 (Affinity Capture-MS; 3 records), MRPL39 (Affinity Capture-MS; 3 records), MRPL44 (Affinity Capture-MS; 3 records), MRPL47 (Affinity Capture-MS; 3 records), MTIF2 (Affinity Capture-MS; 3 records), C1QBP (Proximity Label-MS; 2 records), C6orf203 (Affinity Capture-MS; 2 records), CASQ2 (Affinity Capture-MS; 2 records), CLPP (Proximity Label-MS; 2 records), CS (Proximity Label-MS; 2 records)
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL21 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Protein complexes (CORUM) (2)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
2 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| 55S ribosome, mitochondrial | 78 | MRPS30, MRPL1, MRPL14, MRPL41, MRPL45, MRPL50, MRPL54, MRPS18B, MRPS2, MRPS21, MRPS34, MRPL17, MRPS6, MRPS17, MRPS31, MRPS33, MRPL21, MRPL24, MRPS10, MRPS11, MRPL12, MRPL22, MRPL47, MRPL49, MRPS35, MRPS7, MRPL28, MRPL37, MRPL40, MRPL48, MRPS18A, MRPS22, MRPS23, MRPL13, MRPL46, MRPS28, MRPL16, MRPL23, MRPL39, MRPL52, MRPL53, MRPL19, MRPL42, MRPL44, MRPL11, MRPL2, MRPL27, MRPL33, MRPL34, MRPL35, MRPS25, MRPS26, DAP3, MRPL18, MRPL38, MRPL9, MRPS12, MRPS27, MRPS5, MRPS9, MRPL20, MRPL30, MRPL36, MRPL43, MRPS14, KGD4, MRPL32, MRPL4, MRPL51, MRPS15, MRPS16, MRPL3, MRPL55, MRPS18C, LACTB, MRPL10, MRPL15, MRPS24 |
| 39S ribosomal subunit, mitochondrial | 48 | LACTB, MRPL1, MRPL15, MRPL18, MRPL2, MRPL35, MRPL37, MRPL51, MRPL16, MRPL19, MRPL54, MRPL24, MRPL27, MRPL30, MRPL32, MRPL34, MRPL36, MRPL38, MRPL42, MRPL12, MRPL21, MRPL28, MRPL44, MRPL45, MRPL9, MRPL17, MRPL43, MRPL49, MRPL50, MRPL13, MRPL20, MRPL4, MRPL41, MRPL46, MRPL47, MRPL48, MRPL52, MRPL10, MRPL14, MRPL23, MRPL39, MRPL40, MRPL53, MRPL55, MRPL11, MRPL22, MRPL3, MRPL33 |
Disease & clinical
Genetic variants
Variant evidence for MRPL21: 43 ClinVar records (0 pathogenic / likely pathogenic).
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 594):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 11:68896513–68896514 | donor_loss | 1.0000 | 5 |
| 11:68897925–68897926 | donor_loss | 1.0000 | 5 |
| 11:68898013–68898014 | acceptor_loss | 1.0000 | 5 |
| 11:68903721–68903722 | donor_loss | 1.0000 | 5 |
| 11:68892994–68892995 | acceptor_loss | 0.9900 | 6 |
| 11:68896679–68896680 | acceptor_loss | 0.9900 | 6 |
| 11:68898013 | acceptor_loss | 0.9900 | |
| 11:68893317 | donor_gain | 0.9800 | |
| 11:68896513 | donor_loss | 0.9800 | |
| 11:68893417 | donor_gain | 0.9700 |
AlphaMissense
327 missense substitutions predicted likely pathogenic (of 1,301 scored), across 90 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D112 | 8 | 0.959 | 0.983 |
| F96 | 8 | 0.928 | 0.994 |
| F141 | 8 | 0.897 | 0.985 |
| W106 | 7 | 0.926 | 0.954 |
| F174 | 7 | 0.895 | 0.983 |
| E162 | 7 | 0.833 | 0.974 |
| Q105 | 7 | 0.814 | 0.964 |
| G145 | 6 | 0.939 | 0.983 |
| P147 | 6 | 0.916 | 0.960 |
| K132 | 6 | 0.903 | 0.920 |
| K107 | 6 | 0.878 | 0.975 |
| I195 | 6 | 0.862 | 0.991 |
| V108 | 6 | 0.861 | 0.983 |
| V98 | 6 | 0.760 | 0.974 |
| V83 | 6 | 0.748 | 0.934 |
| V99 | 6 | 0.733 | 0.984 |
| G137 | 5 | 0.944 | 0.969 |
| V156 | 5 | 0.881 | 0.981 |
| V133 | 5 | 0.879 | 0.976 |
| G125 | 5 | 0.862 | 0.966 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
4 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Lung Adenocarcinoma (validation) | unfavorable | 9.88e-05 |
| Head and Neck Squamous Cell Carcinoma (TCGA) | unfavorable | 0.000132 |
| Lung Adenocarcinoma (TCGA) | unfavorable | 0.000198 |
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 0.000824 |
Disease associations
OMIM: gene MIM:611834 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067164 (SINGLE PROTEIN)
PharmGKB: 1 entry (CPIC guideline: no)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.23 | Kd | 5949 | nM | CHEMBL3752910 |
| 5.23 | ED50 | 5949 | nM | CHEMBL3752910 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149886: Binding affinity to human MRPL21 incubated for 45 mins by Kinobead based pull down assay | kd | 5.9488 | uM |
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases expression, increases abundance | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| lead acetate | affects cotreatment, increases expression | 1 |
| nobiletin | decreases reaction, decreases expression | 1 |
| sodium arsenate | decreases expression, decreases reaction | 1 |
| arsenite | increases reaction, affects binding | 1 |
| manganese chloride | increases expression, affects cotreatment, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Acetaminophen | affects cotreatment, decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Asbestos, Crocidolite | increases expression | 1 |
| Copper Sulfate | decreases expression, increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652928 | Binding | Binding affinity to human MRPL21 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — *ChemMedChem* |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Predicted chemistry — Sugi Predict
The predicted patent-compound landscape for MRPL21 across ~30M SureChEMBL compounds — explore on Sugi Predict.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.